Durable B‐Cell Impairment While Sparing <scp>IgA</scp> B Cells After Ocrelizumab Therapy in Multiple Sclerosis

Our findings support an increased regulatory phenotype of remaining B cells under treatment with OCR and replenishment of undifferentiated B cells accumulating features of inflammatory and migratory patterns after OCR discontinuation, counterbalanced by an increased proportion of regulatory B cells.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2025-08-08
DOI
https://doi.org/10.1002/acn3.70135
Citations
1
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

Emmanuelle Le Page, Pierre Labauge, Jerome De Seze, Stéphane Rodriguez et al.
1 citations
Annals of Clinical and Translational Neurology
T-cell and B-cell Immunology
0.80
article

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

Emmanuelle Le Page, Pierre Labauge, Jerome De Seze, Stéphane Rodriguez, Aurélie Ruet, Emilie Dugast, Pierre‐Antoine Gourraud, Laureline Berthelot, David Axel Laplaud, Catarina Raposo, Arnaud Nicot, Christine Lebrun‐Frénay, Fabienne Le Frère, Laure Michel, Inès Doghri, Alexandra Garcia, Eric Berger, Olivier Casez, Sandrine Wiertlewski, Eric Thouvenot, Sandra Vukusic
article en
1 citations

Abstract

Our findings support an increased regulatory phenotype of remaining B cells under treatment with OCR and replenishment of undifferentiated B cells accumulating features of inflammatory and migratory patterns after OCR discontinuation, counterbalanced by an increased proportion of regulatory B cells.

Annals of Clinical and Translational NeurologyVol. 12(11)
Université Claude Bernard Lyon 1 (FR), Roche (Switzerland) (CH), Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Université de Montpellier (FR), Multiple Sclerosis Foundation (US), Centre Hospitalier Universitaire de Grenoble (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Nice (FR), Université Rennes 2 (FR), Centre Hospitalier Universitaire de Besançon (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre de Recherche en Neurosciences de Lyon (FR), Centre Hospitalier Universitaire de Tours (FR), Hôpital Bretonneau (FR), Observatoire Français de la Sclérose en Plaques (FR), Centre Hospitalier Universitaire de Nîmes (FR), Hôpital Pierre Wertheimer (FR), CIC Rennes (FR), Neurocentre Magendie (FR), Centre d'Investigation Clinique de Nantes (FR), Établissement Français du Sang (FR), Hôpital Pasteur (FR), Hôpitaux Universitaires de Strasbourg (FR), Centre Hospitalier Universitaire de Rennes (FR), Institut de Génomique Fonctionnelle (FR), Hôpital Civil, Strasbourg (FR), Université de Rennes (FR), Nantes Université (FR)
F. Hoffmann-La Roche
Good health and well-being
Openalex Percentile: Top 25%
T-cell and B-cell Immunology
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.